Pharma & Healthcare
Global Swine Influenza Vaccines Market Research Report 2025
- Sep 09, 25
- ID: 497228
- Pages: 82
- Figures: 83
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Influenza Vaccines.
The Swine Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Commodity Pig
Breeding Pig
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Swine Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Influenza Vaccines.
The Swine Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Commodity Pig
Breeding Pig
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Swine Influenza Vaccines Market Overview
1.1 Product Definition
1.2 Swine Influenza Vaccines by Type
1.2.1 Global Swine Influenza Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Swine Influenza Vaccines by Application
1.3.1 Global Swine Influenza Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Commodity Pig
1.3.3 Breeding Pig
1.4 Global Swine Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Influenza Vaccines Revenue 2020-2031
1.4.2 Global Swine Influenza Vaccines Sales 2020-2031
1.4.3 Global Swine Influenza Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Swine Influenza Vaccines Market Competition by Manufacturers
2.1 Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Swine Influenza Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Swine Influenza Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Influenza Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Swine Influenza Vaccines, Date of Enter into This Industry
2.8 Global Swine Influenza Vaccines Market Competitive Situation and Trends
2.8.1 Global Swine Influenza Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Swine Influenza Vaccines Players Market Share by Revenue
2.8.3 Global Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Swine Influenza Vaccines Market Scenario by Region
3.1 Global Swine Influenza Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Swine Influenza Vaccines Sales by Region: 2020-2031
3.2.1 Global Swine Influenza Vaccines Sales by Region: 2020-2025
3.2.2 Global Swine Influenza Vaccines Sales by Region: 2026-2031
3.3 Global Swine Influenza Vaccines Revenue by Region: 2020-2031
3.3.1 Global Swine Influenza Vaccines Revenue by Region: 2020-2025
3.3.2 Global Swine Influenza Vaccines Revenue by Region: 2026-2031
3.4 North America Swine Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Swine Influenza Vaccines Sales by Country (2020-2031)
3.4.3 North America Swine Influenza Vaccines Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Swine Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Swine Influenza Vaccines Sales by Country (2020-2031)
3.5.3 Europe Swine Influenza Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Influenza Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Swine Influenza Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Swine Influenza Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Swine Influenza Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Swine Influenza Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Swine Influenza Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Swine Influenza Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Swine Influenza Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Influenza Vaccines Sales by Type (2020-2031)
4.1.1 Global Swine Influenza Vaccines Sales by Type (2020-2025)
4.1.2 Global Swine Influenza Vaccines Sales by Type (2026-2031)
4.1.3 Global Swine Influenza Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Swine Influenza Vaccines Revenue by Type (2020-2031)
4.2.1 Global Swine Influenza Vaccines Revenue by Type (2020-2025)
4.2.2 Global Swine Influenza Vaccines Revenue by Type (2026-2031)
4.2.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Swine Influenza Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Swine Influenza Vaccines Sales by Application (2020-2031)
5.1.1 Global Swine Influenza Vaccines Sales by Application (2020-2025)
5.1.2 Global Swine Influenza Vaccines Sales by Application (2026-2031)
5.1.3 Global Swine Influenza Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Swine Influenza Vaccines Revenue by Application (2020-2031)
5.2.1 Global Swine Influenza Vaccines Revenue by Application (2020-2025)
5.2.2 Global Swine Influenza Vaccines Revenue by Application (2026-2031)
5.2.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Swine Influenza Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chengdu TECBOND
6.1.1 Chengdu TECBOND Company Information
6.1.2 Chengdu TECBOND Description and Business Overview
6.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
6.1.5 Chengdu TECBOND Recent Developments/Updates
6.2 Green Cross Veterinary
6.2.1 Green Cross Veterinary Company Information
6.2.2 Green Cross Veterinary Description and Business Overview
6.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
6.2.5 Green Cross Veterinary Recent Developments/Updates
6.3 Hipra
6.3.1 Hipra Company Information
6.3.2 Hipra Description and Business Overview
6.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hipra Swine Influenza Vaccines Product Portfolio
6.3.5 Hipra Recent Developments/Updates
6.4 MSD Animal Health (Merck)
6.4.1 MSD Animal Health (Merck) Company Information
6.4.2 MSD Animal Health (Merck) Description and Business Overview
6.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
6.4.5 MSD Animal Health (Merck) Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Company Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zoetis Swine Influenza Vaccines Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 CAHIC
6.6.1 CAHIC Company Information
6.6.2 CAHIC Description and Business Overview
6.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CAHIC Swine Influenza Vaccines Product Portfolio
6.6.5 CAHIC Recent Developments/Updates
6.7 Boehringer Ingelheim
6.7.1 Boehringer Ingelheim Company Information
6.7.2 Boehringer Ingelheim Description and Business Overview
6.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Ceva
6.8.1 Ceva Company Information
6.8.2 Ceva Description and Business Overview
6.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ceva Swine Influenza Vaccines Product Portfolio
6.8.5 Ceva Recent Developments/Updates
6.9 Ringpu Biology
6.9.1 Ringpu Biology Company Information
6.9.2 Ringpu Biology Description and Business Overview
6.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
6.9.5 Ringpu Biology Recent Developments/Updates
6.10 DHN
6.10.1 DHN Company Information
6.10.2 DHN Description and Business Overview
6.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DHN Swine Influenza Vaccines Product Portfolio
6.10.5 DHN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Influenza Vaccines Industry Chain Analysis
7.2 Swine Influenza Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Influenza Vaccines Production Mode & Process Analysis
7.4 Swine Influenza Vaccines Sales and Marketing
7.4.1 Swine Influenza Vaccines Sales Channels
7.4.2 Swine Influenza Vaccines Distributors
7.5 Swine Influenza Vaccines Customer Analysis
8 Swine Influenza Vaccines Market Dynamics
8.1 Swine Influenza Vaccines Industry Trends
8.2 Swine Influenza Vaccines Market Drivers
8.3 Swine Influenza Vaccines Market Challenges
8.4 Swine Influenza Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Swine Influenza Vaccines by Type
1.2.1 Global Swine Influenza Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Swine Influenza Vaccines by Application
1.3.1 Global Swine Influenza Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Commodity Pig
1.3.3 Breeding Pig
1.4 Global Swine Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Influenza Vaccines Revenue 2020-2031
1.4.2 Global Swine Influenza Vaccines Sales 2020-2031
1.4.3 Global Swine Influenza Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Swine Influenza Vaccines Market Competition by Manufacturers
2.1 Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Swine Influenza Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Swine Influenza Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Influenza Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Swine Influenza Vaccines, Date of Enter into This Industry
2.8 Global Swine Influenza Vaccines Market Competitive Situation and Trends
2.8.1 Global Swine Influenza Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Swine Influenza Vaccines Players Market Share by Revenue
2.8.3 Global Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Swine Influenza Vaccines Market Scenario by Region
3.1 Global Swine Influenza Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Swine Influenza Vaccines Sales by Region: 2020-2031
3.2.1 Global Swine Influenza Vaccines Sales by Region: 2020-2025
3.2.2 Global Swine Influenza Vaccines Sales by Region: 2026-2031
3.3 Global Swine Influenza Vaccines Revenue by Region: 2020-2031
3.3.1 Global Swine Influenza Vaccines Revenue by Region: 2020-2025
3.3.2 Global Swine Influenza Vaccines Revenue by Region: 2026-2031
3.4 North America Swine Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Swine Influenza Vaccines Sales by Country (2020-2031)
3.4.3 North America Swine Influenza Vaccines Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Swine Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Swine Influenza Vaccines Sales by Country (2020-2031)
3.5.3 Europe Swine Influenza Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Influenza Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Swine Influenza Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Swine Influenza Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Swine Influenza Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Swine Influenza Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Swine Influenza Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Swine Influenza Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Swine Influenza Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Influenza Vaccines Sales by Type (2020-2031)
4.1.1 Global Swine Influenza Vaccines Sales by Type (2020-2025)
4.1.2 Global Swine Influenza Vaccines Sales by Type (2026-2031)
4.1.3 Global Swine Influenza Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Swine Influenza Vaccines Revenue by Type (2020-2031)
4.2.1 Global Swine Influenza Vaccines Revenue by Type (2020-2025)
4.2.2 Global Swine Influenza Vaccines Revenue by Type (2026-2031)
4.2.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Swine Influenza Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Swine Influenza Vaccines Sales by Application (2020-2031)
5.1.1 Global Swine Influenza Vaccines Sales by Application (2020-2025)
5.1.2 Global Swine Influenza Vaccines Sales by Application (2026-2031)
5.1.3 Global Swine Influenza Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Swine Influenza Vaccines Revenue by Application (2020-2031)
5.2.1 Global Swine Influenza Vaccines Revenue by Application (2020-2025)
5.2.2 Global Swine Influenza Vaccines Revenue by Application (2026-2031)
5.2.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Swine Influenza Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chengdu TECBOND
6.1.1 Chengdu TECBOND Company Information
6.1.2 Chengdu TECBOND Description and Business Overview
6.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
6.1.5 Chengdu TECBOND Recent Developments/Updates
6.2 Green Cross Veterinary
6.2.1 Green Cross Veterinary Company Information
6.2.2 Green Cross Veterinary Description and Business Overview
6.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
6.2.5 Green Cross Veterinary Recent Developments/Updates
6.3 Hipra
6.3.1 Hipra Company Information
6.3.2 Hipra Description and Business Overview
6.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hipra Swine Influenza Vaccines Product Portfolio
6.3.5 Hipra Recent Developments/Updates
6.4 MSD Animal Health (Merck)
6.4.1 MSD Animal Health (Merck) Company Information
6.4.2 MSD Animal Health (Merck) Description and Business Overview
6.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
6.4.5 MSD Animal Health (Merck) Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Company Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zoetis Swine Influenza Vaccines Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 CAHIC
6.6.1 CAHIC Company Information
6.6.2 CAHIC Description and Business Overview
6.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CAHIC Swine Influenza Vaccines Product Portfolio
6.6.5 CAHIC Recent Developments/Updates
6.7 Boehringer Ingelheim
6.7.1 Boehringer Ingelheim Company Information
6.7.2 Boehringer Ingelheim Description and Business Overview
6.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Ceva
6.8.1 Ceva Company Information
6.8.2 Ceva Description and Business Overview
6.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ceva Swine Influenza Vaccines Product Portfolio
6.8.5 Ceva Recent Developments/Updates
6.9 Ringpu Biology
6.9.1 Ringpu Biology Company Information
6.9.2 Ringpu Biology Description and Business Overview
6.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
6.9.5 Ringpu Biology Recent Developments/Updates
6.10 DHN
6.10.1 DHN Company Information
6.10.2 DHN Description and Business Overview
6.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DHN Swine Influenza Vaccines Product Portfolio
6.10.5 DHN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Influenza Vaccines Industry Chain Analysis
7.2 Swine Influenza Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Influenza Vaccines Production Mode & Process Analysis
7.4 Swine Influenza Vaccines Sales and Marketing
7.4.1 Swine Influenza Vaccines Sales Channels
7.4.2 Swine Influenza Vaccines Distributors
7.5 Swine Influenza Vaccines Customer Analysis
8 Swine Influenza Vaccines Market Dynamics
8.1 Swine Influenza Vaccines Industry Trends
8.2 Swine Influenza Vaccines Market Drivers
8.3 Swine Influenza Vaccines Market Challenges
8.4 Swine Influenza Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Swine Influenza Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Swine Influenza Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Swine Influenza Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Swine Influenza Vaccines Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Swine Influenza Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Swine Influenza Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Swine Influenza Vaccines Average Price (USD/K Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Swine Influenza Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Swine Influenza Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Swine Influenza Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Swine Influenza Vaccines Sales by Region (2020-2025) & (M Units)
Table 18. Global Swine Influenza Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Swine Influenza Vaccines Sales by Region (2026-2031) & (M Units)
Table 20. Global Swine Influenza Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Swine Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Swine Influenza Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Swine Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Swine Influenza Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 27. North America Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 28. North America Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 32. Europe Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 33. Europe Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Swine Influenza Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Swine Influenza Vaccines Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Swine Influenza Vaccines Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Swine Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Swine Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Swine Influenza Vaccines Sales (M Units) by Type (2020-2025)
Table 51. Global Swine Influenza Vaccines Sales (M Units) by Type (2026-2031)
Table 52. Global Swine Influenza Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Swine Influenza Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Swine Influenza Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Swine Influenza Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Swine Influenza Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Swine Influenza Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2020-2025)
Table 59. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2026-2031)
Table 60. Global Swine Influenza Vaccines Sales (M Units) by Application (2020-2025)
Table 61. Global Swine Influenza Vaccines Sales (M Units) by Application (2026-2031)
Table 62. Global Swine Influenza Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Swine Influenza Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Swine Influenza Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Swine Influenza Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Swine Influenza Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Swine Influenza Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2020-2025)
Table 69. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2026-2031)
Table 70. Chengdu TECBOND Company Information
Table 71. Chengdu TECBOND Description and Business Overview
Table 72. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 73. Chengdu TECBOND Swine Influenza Vaccines Product
Table 74. Chengdu TECBOND Recent Developments/Updates
Table 75. Green Cross Veterinary Company Information
Table 76. Green Cross Veterinary Description and Business Overview
Table 77. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 78. Green Cross Veterinary Swine Influenza Vaccines Product
Table 79. Green Cross Veterinary Recent Developments/Updates
Table 80. Hipra Company Information
Table 81. Hipra Description and Business Overview
Table 82. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 83. Hipra Swine Influenza Vaccines Product
Table 84. Hipra Recent Developments/Updates
Table 85. MSD Animal Health (Merck) Company Information
Table 86. MSD Animal Health (Merck) Description and Business Overview
Table 87. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 88. MSD Animal Health (Merck) Swine Influenza Vaccines Product
Table 89. MSD Animal Health (Merck) Recent Developments/Updates
Table 90. Zoetis Company Information
Table 91. Zoetis Description and Business Overview
Table 92. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 93. Zoetis Swine Influenza Vaccines Product
Table 94. Zoetis Recent Developments/Updates
Table 95. CAHIC Company Information
Table 96. CAHIC Description and Business Overview
Table 97. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 98. CAHIC Swine Influenza Vaccines Product
Table 99. CAHIC Recent Developments/Updates
Table 100. Boehringer Ingelheim Company Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 103. Boehringer Ingelheim Swine Influenza Vaccines Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Ceva Company Information
Table 106. Ceva Description and Business Overview
Table 107. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 108. Ceva Swine Influenza Vaccines Product
Table 109. Ceva Recent Developments/Updates
Table 110. Ringpu Biology Company Information
Table 111. Ringpu Biology Description and Business Overview
Table 112. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 113. Ringpu Biology Swine Influenza Vaccines Product
Table 114. Ringpu Biology Recent Developments/Updates
Table 115. DHN Company Information
Table 116. DHN Description and Business Overview
Table 117. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 118. DHN Swine Influenza Vaccines Product
Table 119. DHN Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Swine Influenza Vaccines Distributors List
Table 123. Swine Influenza Vaccines Customers List
Table 124. Swine Influenza Vaccines Market Trends
Table 125. Swine Influenza Vaccines Market Drivers
Table 126. Swine Influenza Vaccines Market Challenges
Table 127. Swine Influenza Vaccines Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Swine Influenza Vaccines
Figure 2. Global Swine Influenza Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Swine Influenza Vaccines Market Share by Type: 2024 & 2031
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Swine Influenza Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Swine Influenza Vaccines Market Share by Application: 2024 & 2031
Figure 8. Commodity Pig
Figure 9. Breeding Pig
Figure 10. Global Swine Influenza Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Swine Influenza Vaccines Market Size (2020-2031) & (US$ Million)
Figure 12. Global Swine Influenza Vaccines Sales (2020-2031) & (M Units)
Figure 13. Global Swine Influenza Vaccines Average Price (USD/K Unit) & (2020-2031)
Figure 14. Swine Influenza Vaccines Report Years Considered
Figure 15. Swine Influenza Vaccines Sales Share by Manufacturers in 2024
Figure 16. Global Swine Influenza Vaccines Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Swine Influenza Vaccines Players: Market Share by Revenue in Swine Influenza Vaccines in 2024
Figure 18. Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Swine Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 21. North America Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 22. the United States Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 25. Europe Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. Germany Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Swine Influenza Vaccines Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Swine Influenza Vaccines Revenue Market Share by Region (2020-2031)
Figure 33. China Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 43. Latin America Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Swine Influenza Vaccines by Type (2020-2031)
Figure 53. Global Revenue Market Share of Swine Influenza Vaccines by Type (2020-2031)
Figure 54. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Swine Influenza Vaccines by Application (2020-2031)
Figure 56. Global Revenue Market Share of Swine Influenza Vaccines by Application (2020-2031)
Figure 57. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2020-2031)
Figure 58. Swine Influenza Vaccines Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Swine Influenza Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Swine Influenza Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Swine Influenza Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Swine Influenza Vaccines Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Swine Influenza Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Swine Influenza Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Swine Influenza Vaccines Average Price (USD/K Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Swine Influenza Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Swine Influenza Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Swine Influenza Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Swine Influenza Vaccines Sales by Region (2020-2025) & (M Units)
Table 18. Global Swine Influenza Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Swine Influenza Vaccines Sales by Region (2026-2031) & (M Units)
Table 20. Global Swine Influenza Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Swine Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Swine Influenza Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Swine Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Swine Influenza Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 27. North America Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 28. North America Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 32. Europe Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 33. Europe Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Swine Influenza Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Swine Influenza Vaccines Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Swine Influenza Vaccines Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Swine Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Swine Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Swine Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Swine Influenza Vaccines Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Swine Influenza Vaccines Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Swine Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Swine Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Swine Influenza Vaccines Sales (M Units) by Type (2020-2025)
Table 51. Global Swine Influenza Vaccines Sales (M Units) by Type (2026-2031)
Table 52. Global Swine Influenza Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Swine Influenza Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Swine Influenza Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Swine Influenza Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Swine Influenza Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Swine Influenza Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2020-2025)
Table 59. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2026-2031)
Table 60. Global Swine Influenza Vaccines Sales (M Units) by Application (2020-2025)
Table 61. Global Swine Influenza Vaccines Sales (M Units) by Application (2026-2031)
Table 62. Global Swine Influenza Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Swine Influenza Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Swine Influenza Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Swine Influenza Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Swine Influenza Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Swine Influenza Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2020-2025)
Table 69. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2026-2031)
Table 70. Chengdu TECBOND Company Information
Table 71. Chengdu TECBOND Description and Business Overview
Table 72. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 73. Chengdu TECBOND Swine Influenza Vaccines Product
Table 74. Chengdu TECBOND Recent Developments/Updates
Table 75. Green Cross Veterinary Company Information
Table 76. Green Cross Veterinary Description and Business Overview
Table 77. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 78. Green Cross Veterinary Swine Influenza Vaccines Product
Table 79. Green Cross Veterinary Recent Developments/Updates
Table 80. Hipra Company Information
Table 81. Hipra Description and Business Overview
Table 82. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 83. Hipra Swine Influenza Vaccines Product
Table 84. Hipra Recent Developments/Updates
Table 85. MSD Animal Health (Merck) Company Information
Table 86. MSD Animal Health (Merck) Description and Business Overview
Table 87. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 88. MSD Animal Health (Merck) Swine Influenza Vaccines Product
Table 89. MSD Animal Health (Merck) Recent Developments/Updates
Table 90. Zoetis Company Information
Table 91. Zoetis Description and Business Overview
Table 92. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 93. Zoetis Swine Influenza Vaccines Product
Table 94. Zoetis Recent Developments/Updates
Table 95. CAHIC Company Information
Table 96. CAHIC Description and Business Overview
Table 97. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 98. CAHIC Swine Influenza Vaccines Product
Table 99. CAHIC Recent Developments/Updates
Table 100. Boehringer Ingelheim Company Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 103. Boehringer Ingelheim Swine Influenza Vaccines Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Ceva Company Information
Table 106. Ceva Description and Business Overview
Table 107. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 108. Ceva Swine Influenza Vaccines Product
Table 109. Ceva Recent Developments/Updates
Table 110. Ringpu Biology Company Information
Table 111. Ringpu Biology Description and Business Overview
Table 112. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 113. Ringpu Biology Swine Influenza Vaccines Product
Table 114. Ringpu Biology Recent Developments/Updates
Table 115. DHN Company Information
Table 116. DHN Description and Business Overview
Table 117. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 118. DHN Swine Influenza Vaccines Product
Table 119. DHN Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Swine Influenza Vaccines Distributors List
Table 123. Swine Influenza Vaccines Customers List
Table 124. Swine Influenza Vaccines Market Trends
Table 125. Swine Influenza Vaccines Market Drivers
Table 126. Swine Influenza Vaccines Market Challenges
Table 127. Swine Influenza Vaccines Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Swine Influenza Vaccines
Figure 2. Global Swine Influenza Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Swine Influenza Vaccines Market Share by Type: 2024 & 2031
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Swine Influenza Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Swine Influenza Vaccines Market Share by Application: 2024 & 2031
Figure 8. Commodity Pig
Figure 9. Breeding Pig
Figure 10. Global Swine Influenza Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Swine Influenza Vaccines Market Size (2020-2031) & (US$ Million)
Figure 12. Global Swine Influenza Vaccines Sales (2020-2031) & (M Units)
Figure 13. Global Swine Influenza Vaccines Average Price (USD/K Unit) & (2020-2031)
Figure 14. Swine Influenza Vaccines Report Years Considered
Figure 15. Swine Influenza Vaccines Sales Share by Manufacturers in 2024
Figure 16. Global Swine Influenza Vaccines Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Swine Influenza Vaccines Players: Market Share by Revenue in Swine Influenza Vaccines in 2024
Figure 18. Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Swine Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 21. North America Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 22. the United States Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 25. Europe Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. Germany Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Swine Influenza Vaccines Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Swine Influenza Vaccines Revenue Market Share by Region (2020-2031)
Figure 33. China Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 43. Latin America Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Swine Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Swine Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Swine Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Swine Influenza Vaccines by Type (2020-2031)
Figure 53. Global Revenue Market Share of Swine Influenza Vaccines by Type (2020-2031)
Figure 54. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Swine Influenza Vaccines by Application (2020-2031)
Figure 56. Global Revenue Market Share of Swine Influenza Vaccines by Application (2020-2031)
Figure 57. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2020-2031)
Figure 58. Swine Influenza Vaccines Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232